Certara's Q2 EPS of $0.07 missed estimate by $0.03 and revenue by $2.7M; shares dropped to $12.51.
Certara (NASDAQ: CERT) reported Q2 EPS of $0.07, missing $0.10 estimate by $0.03, and revenue of $93.31M vs $96.01M consensus. YoY revenue grew 3.2%, and FY24 guidance is $0.41-$0.46 EPS. Despite this, shares dropped, reaching $12.51. Certara offers software products & tech-enabled services for biosimulation in drug discovery, research, and more.
August 10, 2024
3 Articles